94 related articles for article (PubMed ID: 26243649)
1. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center.
Hwang JP; Granwehr BP; Torres HA; Suarez-Almazor ME; Giordano TP; Barbo AG; Lin HY; Fisch MJ; Chiao EY
J Oncol Pract; 2015 Sep; 11(5):384-90. PubMed ID: 26243649
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
3. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.
D'Addario G; Dieterle A; Torhorst J; Maibach R; Stahel R; Egli F; Lohri A; Cavalli F; Fey M; Ketterer N; Cerny T
Leuk Lymphoma; 2003 Jan; 44(1):133-8. PubMed ID: 12691153
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
Alldredge J; Leaf MC; Patel P; Coakley K; Longoria T; McLaren C; Randall LM
Int J Gynecol Cancer; 2020 Jun; 30(6):772-776. PubMed ID: 32156714
[TBL] [Abstract][Full Text] [Related]
5. HIV Testing Among US High School Students and Young Adults.
Van Handel M; Kann L; Olsen EO; Dietz P
Pediatrics; 2016 Feb; 137(2):e20152700. PubMed ID: 26787047
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
7. Implementing routine HIV screening in an urban pediatric emergency department.
Hack CM; Scarfi CA; Sivitz AB; Rosen MD
Pediatr Emerg Care; 2013 Mar; 29(3):319-23. PubMed ID: 23426243
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
9. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
10. Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.
Merz L; Zimmermann S; Peters S; Cavassini M; Darling KE
Oncologist; 2016 Oct; 21(10):1176-1182. PubMed ID: 27440062
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional evaluation of opt-in testing for sexually transmitted and blood-borne infections in three Canadian provincial correctional facilities: a missed opportunity for public health?
Gratrix J; Smyczek P; Bertholet L; Lee MC; Pyne D; Woods D; Courtney K; Ahmed R
Int J Prison Health; 2019 Aug; 15(3):273-281. PubMed ID: 31329036
[TBL] [Abstract][Full Text] [Related]
12. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
13. A routine HIV screening program in a South Carolina community health center in an area of low HIV prevalence.
Weis KE; Liese AD; Hussey J; Coleman J; Powell P; Gibson JJ; Duffus WA
AIDS Patient Care STDS; 2009 Apr; 23(4):251-8. PubMed ID: 19281345
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of prior HIV testing and associated factors among MSM in Zhejiang Province, China: a cross-sectional study.
Li R; Pan X; Ma Q; Wang H; He L; Jiang T; Wang D; Zhang Y; Zhang X; Xia S
BMC Public Health; 2016 Nov; 16(1):1152. PubMed ID: 27832761
[TBL] [Abstract][Full Text] [Related]
15. Cost analysis and benefits of opt-out HIV testing at a tertiary care centre in northern India.
Minz RW; Khairwa A; Aggarwal R; Kaur H; Singh S; Sharma A; Varma S; Mathuria SN; Pasricha N
Int J STD AIDS; 2014 Apr; 25(5):341-7. PubMed ID: 24100284
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
17. [An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].
Tang HL; Xu J; Han J; Li J; Mao YR
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):711-717. PubMed ID: 28763920
[No Abstract] [Full Text] [Related]
18. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of opt-out inpatient HIV screening at an urban teaching hospital.
Osorio G; Hoenigl M; Quartarolo J; Barger K; Morris SR; Reed SL; Lee J; Little SJ
AIDS Care; 2017 Aug; 29(8):1014-1018. PubMed ID: 28114789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
